2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Molecular Testing, Profiling, Treatment Considerations, Combination Therapy, Therapy Sequence, Biological Therapies, Antibody Therapy, Non-Biological Therapies, Artificial Intelligence (AI), Machine Learning, Biological Processes, Apoptosis, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Clinical Practice (Health Services and Quality), Clinical Guidelines, Quality of Care, Diseases, Bone Marrow Failure Syndromes, Genetic Disorders, Hemoglobinopathies, Immunology, Autoimmune Disorders, Autoimmune Hemolytic Anemia, Infectious Diseases, Other Pathogens, Metabolic Disorders, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Real-World Evidence, Registries, Study Population, Human, Adult, Elderly, Young Adult, Animal Model
PAPER

4625 Distinct hepatic immature reticulocytes define ineffective stress erythropoiesis in severe neonatal anemia

Marie Amalie Balamurugan, MS, Juanitaa George Raj, B.Tech2, Arjun Surya Subrramanya, B.Tech3, Sayma Azeem, PhD4, Krishnan MohanKumar, PhD5, Balamurugan Ramatchandirin, PhD6
1 University of Texas Southwestern Medical Center, Dallas, Texas, United States
2 University of Texas Southwestern Medical Center, Dallas, Texas, United States
3 University of Texas Southwestern Medical Center, Dallas, Texas, United States
4 University of Texas Southwestern Medical Center, Dallas, Texas, United States
5 University of Texas Southwestern Medical Center, Dallas, Texas, United States
6 University of Texas Southwestern Medical Center, Dallas, Texas, United States

Background: Anemia is common in extremely preterm and critically ill infants who often requires red blood cell (RBC) transfusion, but whether transfusion restores endogenous erythropoiesis remains unknown. We characterized the temporal and tissue-specific dynamics of endogenous erythroid recovery following severe anemia and RBC transfusion.

Methods: Severe neonatal anemia was induced in C57BL/6 mice by facial vein phlebotomy (P2–P10), followed by packed RBC transfusion on P11. Hematologic recovery, erythroid populations in blood, liver, spleen, and bone marrow were assessed at P11, P14, and P21 by Sysmex hematology analyzer and flow cytometry using CD71, Ter119, Thiazole Orange, Hoechst, and MitoTracker. Hepatic, spleen, and bone marrow-derived CD71⁺ erythroid cells were cocultured with PBMCs ± LPS for cytokine analysis (n=6/group).

Results: At P11, anemic mice significantly reduced hemoglobin by 52.3% compared with controls (5.17 ± 0.09 vs 10.84 ± 0.10; g/dL; P<0.0001), hematocrit by 35.4% (28.42 ± 0.26 vs 44.0 ± 0.74; %; P<0.0001) and RBC counts by 55% (2.4 ± 0.2 vs 5.4 ± 0.2 ×10⁶/µL; P<0.0001). Absolute reticulocyte counts increased 26.3-fold (0.06 ± 0.10 vs 1.58 ± 0.07 ×10⁶/µL; P<0.0001), accompanied by 37-fold increase immature reticulocytes counts (304,199 ± 131 vs 8232 ± 26; P<0.0001), and circulating nucleated RBCs were significantly increased 3.67-fold in anemic mice compared with control mice (8.38 ± 0.54% vs 2.28 ± ± 0.17%  P<0.001).

Longitudinal post-anemia evaluation demonstrated that immature reticulocytes remained significantly elevated at P14 (29.3-fold; 214,905 ± 1772 vs 7,327 ± 58; P<0.0001) and remained incompletely normalized at P21 (2.53-fold; 15,309 ± 307 vs 6,063 ± 210; P<0.001). Similarly, nucleated RBCs remained elevated (4.08 ± 0.37% vs 0.075 ± 0.015%). Reduced enucleation and mitochondrial clearance during Ery-B to Ery-C maturation, assessed by CD71, Ter119, Hoechst and MitoTracker by flow cytometry (P<0.001), indicated persistent impairment of terminal erythroid maturation during endogenous stress erythropoiesis.

Following RBC transfusion on P11, absolute reticulocyte counts remained elevated and further increased at P14 (1.449 ± 0.056 vs 1.168 ± 0.034; P<0.05). Similarly, circulating nucleated RBCs nearly 2-fold higher (8.08 ± 0.29% vs 4.08 ± 0.37%; P<0.0001), indicating persistent failure of endogenous stress erythropoiesis.

Analysis of erythroid populations displayed increased hepatic CD71⁺Ter119⁺ erythroid cells in anemic mice (25.6 ± 0.41% vs 17.3 ± 0.20%; P<0.001), accompanied by reduced mature Ery C cells (10.6% vs 15.0%), indicating impaired terminal erythroid maturation. In contrast, Ery C cells in the spleen (0.73 ± 0.03% vs 0.97 ± 0.027%) and bone marrow (0.82 ± 0.02% vs 0.71 ± 0.04%) were unchanged, supporting the liver as the predominant site of developmental stress erythropoiesis.

At P11, immature reticulocytes accumulated in the anemic liver (44.4 ± 0.34% vs 16.4 ± 0.27%; P<0.001), whereas spleen (11.41 ± 0.21% vs 10.97 ± 0.13%) and bone marrow (5.16 ± 0.07% vs 4.56 ± 0.04%) showed no significant changes, identifying the liver as the principal reservoir of persistent immature reticulocytes during severe neonatal anemia.

To assess the immunomodulatory function of hepatic immature erythroid cells, liver, spleen, and bone marrow-derived CD71⁺ erythroid cells were cocultured with PBMCs ± LPS. In the absence of LPS, hepatic CD71⁺ erythroid cells from anemic neonates increased PBMC IL-1β (4.0-fold), TNF-α (2.3-fold), NFκB1 (1.3-fold), and NFκB2 (3.7-fold; (all P<0.001), whereas spleen and bone marrow-derived CD71⁺ erythroid cells did not show inflammatory changes. Following LPS stimulation, bone marrow and spleen-derived CD71⁺ erythroid cells retained canonical immunosuppressive function, reducing IL-1β from 57.4- to 2.2, 1.1-fold and NFκB2 from 3.4- to 1.5, 1.2-fold. In contrast, hepatic CD71⁺ erythroid cells failed to suppress LPS-induced inflammation, with IL-1β increasing to 85.1-fold, NFκB1 to 2.3-fold, and NFκB2 to 6.5-fold.

Conclusions: Severe neonatal anemia induces ineffective stress erythropoiesis characterized by impaired terminal erythroid maturation, hepatic accumulation of immature reticulocytes and NRBCs, and loss of immunosuppressive function in hepatic CD71⁺ erythroid cells. Although RBC transfusion restores hemoglobin, endogenous erythroid recovery remains impaired, revealing a previously unrecognized functional defect in developmental stress erythropoiesis.

Balamurugan Ramatchandirin, PhD: No relevant conflicts of interest to declare.